A recent analysis of an already CE-marked, AI-based system that identifies pneumothorax on chest radiographs revealed a weak point in what has largely been considered a reliable support tool.
Though it is not yet clear why some COVID patients develop thyroiditis and some do not, researchers maintain that their findings “support the hypothesis of a direct thyroid gland involvement in SARS‐CoV‐2 infection.”
At the annual ASTRO meeting, experts shared that not only did the shortened protocol shave weeks off of the scheduled treatment plan, it also did not come at the expense of increased toxicity.
Compared to a group of patients who had not been previously diagnosed with Lyme disease, those who had been infected displayed unusual activity in the frontal lobe of the brain on functional MRI scans.
Research presented this week at the American Society for Radiation Oncology Annual 2022 Meeting argues for the inclusion of radiation therapy as a standard of care in liver cancer patients who are ineligible for resection and other standard therapies.
Nearly 30% of corresponding authors included in the analysis shared that they had witnessed scientific fraud in their department within the last five years.
Previously, CMS determined that coverage for patients receiving treatment was dependent on their being enrolled in a CMS-approved clinical trial under coverage with evidence development (CED).
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
